Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats

References

• Apland JP, Aroniadou-Anderjaska V, Braga MF. (2009). Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro. Neuroscience 159:380–9.
   PubMed Web of Science ®Google Scholar
• Apland JP, Aroniadou-Anderjaska V, Figueiredo TH, et al. (2014). The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302. J Pharmacol Exp Ther 351:359–72.
   PubMed Web of Science ®Google Scholar
• Bajgar J. (2005). Complex view on poisoning with nerve agents and organophosphates. Acta Medica (Hradec Kralove) 48:3–21.
   PubMedGoogle Scholar
• Bajo R, Pusil S, Lopez ME, et al. (2015). Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease. Sci Rep 5:9748.
   PubMed Web of Science ®Google Scholar
• Baze WB. (1993). Soman-induced morphological changes: an overview in the non-human primate. J Appl Toxicol 13:173–7.
   PubMed Web of Science ®Google Scholar
• Biaggioni I. (1992). Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension 20:457–65.
   PubMed Web of Science ®Google Scholar
• Braga MF, Aroniadou-Anderjaska V, Li H, Rogawski MA. (2009). Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J Pharmacol Exp Ther 330:558–66.
   PubMed Web of Science ®Google Scholar
• Brown MA, Brix KA. (1998). Review of health consequences from high-, intermediate-, and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 18:393–408.
   PubMed Web of Science ®Google Scholar
• Burback BL, Cabell LA, Johnson JD, et al. (2013). International journal of toxicology special edition volume of MMB4 DMS. Int J Toxicol 32:3S–4S.
   PubMed Web of Science ®Google Scholar
• Carver CM, Reddy DS. (2013). Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology 230:151–88.
   PubMed Web of Science ®Google Scholar
• Carver CM, Wu X, Reddy DS. (2014). Perimenstrual-like hormonal regulation of extrasynaptic δ-containing GABA-A receptors mediated tonic inhibition and neurosteroid sensitivity. J Neurosci 34:14181–97.
   PubMed Web of Science ®Google Scholar
• Dorandeu F, Carpentier P, Baubichon D, et al. (2005). Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus. Brain Res 1051:164–75.
   PubMed Web of Science ®Google Scholar
• Dunwiddie TV, Masino SA. (2001). The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31–55.
   PubMed Web of Science ®Google Scholar
• Figueiredo T, Aroniadou-Anderjaska V, Qashu F, et al. (2011). Efficacy of topiramate against soman intoxication: attenuation of seizures without neuroprotection. Am J Neuroprot Neuroregen 3:1–7.
   Google Scholar
• Gasior M, Carter RB, Witkin JM. (1999). Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol Sci 20:107–11.
   PubMed Web of Science ®Google Scholar
• Gauthier AC, Mattson RH. (2015). Clobazam: a safe, efficacious, and newly rediscovered therapeutic for epilepsy. CNS Neurosci Ther 21:543–8.
   PubMed Web of Science ®Google Scholar
• Gavish M, Bachman I, Shoukrun R, et al. (1999). Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51:629–50.
   PubMed Web of Science ®Google Scholar
• Gouder N, Fritschy JM, Boison D. (2003). Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44:877–85.
   PubMed Web of Science ®Google Scholar
• Guerrini R, Parmeggiani L. (2006). Topiramate and its clinical applications in epilepsy. Expert Opin Pharmacother 7:811–23.
   PubMed Web of Science ®Google Scholar
• Hambrecht-Wiedbusch VS, Mitchell MF, Firn KA, et al. (2014). Benzodiazepine site agonists differentially alter acetylcholine release in rat amygdala. Anesth Analg 118:1293–300.
   PubMed Web of Science ®Google Scholar
• Iyer R, Iken B, Leon A. (2015). Developments in alternative treatments for organophosphate poisoning. Toxicol Lett 233:200–6.
   PubMed Web of Science ®Google Scholar
• Jokanović M, Kosanović M. (2010). Neurotoxic effects in patients poisoned with organophosphorus pesticides. Environ Toxicol Pharmacol 29:195–201.
   PubMed Web of Science ®Google Scholar
• Jokanović M, Prostran M. (2009). Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 16:2177–88.
   PubMed Web of Science ®Google Scholar
• Koplovitz I, Schulz S. (2010). Perspectives on the use of scopolamine as an adjunct treatment to enhance survival following organophosphorus nerve agent poisoning. Mil Med 175:878–82.
   PubMed Web of Science ®Google Scholar
• Koplovitz I, Schulz SM, Railer RF, et al. (2007). Effect of atropine and diazepam on the efficacy of oxime treatment of nerve agent intoxication. J Med CBR Def 5:1–15.
   Google Scholar
• Lallement G, Carpentier P, Collet A, et al. (1992). Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology 13:557–67.
   PubMed Web of Science ®Google Scholar
• Lumley LA, Moffett MC, Ward TM, et al. (2008). Anticonvulsant and neuroprotective effects of the neurosteroid pregnanolone against soman exposure in rats. Society for Neuroscience, Washington D.C. Abstract number 451.13.
   Google Scholar
• Malva JO, Silva AP, Cunha RA. (2003). Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors. Neurochem Res 28:1501–15.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Dochterman LW, Smith CD, Shih T-M. (1995). Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 16:123–32.
   PubMed Web of Science ®Google Scholar
• McDonough JH, McMonagle J, Copeland T, et al. (1999). Comparative evaluation of benzodiazepines for control of soman-induced seizures. Arch Toxicol 73:473–8.
   PubMed Web of Science ®Google Scholar
• McDonough JH, McMonagle JD, Shih T-M. (2010). Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs. Drug Chem Toxicol 33:279–83.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Shih T-M. (1997). Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 21:559–79.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Zoeffel LD, McMonagle J, et al. (2000). Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 38:1–14.
   PubMed Web of Science ®Google Scholar
• Moffett MC, Stone MF, Schwartz JE, et al. (2010). The neurosteroids allopregnanolone and pregnanolone attenuate soman-induced seizures, performance deficits and brain pathology in rats. Chemical and Biological Defense Science and Technology Conference, Orlando, FL. Abstract #0698.
   Google Scholar
• Moor E, Schirm E, Jacso J, Westerink BH. (1998). Effects of neostigmine and atropine on basal and handling-induced acetylcholine output from ventral hippocampus. Neuroscience 82:819–25.
   PubMed Web of Science ®Google Scholar
• Moore DH, Clifford CB, Crawford IT, et al. (1995). Review of nerve agent inhibitors and reactivators of acetylcholinesterase. In: Quinn DM, Balasubramanian AS, Doctor BP, Taylor P, eds. Enzymes of the cholinesterase family. New York (NY): Plenum Press, 297–304.
   Google Scholar
• More JCA, Nistico R, Dolman NP, et al. (2004). Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. Neuropharmacology 47:46–64.
   PubMed Web of Science ®Google Scholar
• Myhrer T, Enger S, Aas P. (2007). Anticonvulsant effects of damage to structures involved in seizure induction in rats exposed to soman. Neurotoxicology 28:819–28.
   PubMed Web of Science ®Google Scholar
• Myhrer T, Enger S, Aas P. (2010). Roles of perirhinal and posterior piriform cortices in control and generation of seizures: a microinfusion study in rats exposed to soman. Neurotoxicology 31:147–53.
   PubMed Web of Science ®Google Scholar
• Nemoto C, Murakawa M, Hakozaki T, et al. (2013). Effects of dexmedetomidine, midazolam, and propofol on acetylcholine release in the rat cerebral cortex in vivo. J Anesth 27:771–4.
   PubMed Web of Science ®Google Scholar
• Niebauer M, Gruenthal M. (1999). Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 837:263–9.
   PubMed Web of Science ®Google Scholar
• O'Donnell JC, Acon-Chen C, McDonough JH, Shih T-M. (2010a). Comparison of extracellular striatal acetylcholine and brain seizure activity following acute exposure to the nerve agents cyclosarin and tabun in freely moving guinea pigs. Toxicol Mech Methods 20:600–8.
   PubMed Web of Science ®Google Scholar
• O'Donnell JC, McDonough JH, Shih T-M. (2010b). Changes in extracellular striatal acetylcholine and brain seizure activity following acute exposure to nerve agents in freely moving guinea pigs. Toxicol Mech Methods 20:143–52.
   PubMed Web of Science ®Google Scholar
• O'Donnell JC, McDonough JH, Shih T-M. (2011). In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate. Arch Toxicol 85:1607–16.
   PubMed Web of Science ®Google Scholar
• Papadopoulos V, Baraldi M, Guilarte TR, et al. (2006). Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402–9.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. (2009). The rat brain in stereotaxic coordinates: compact. 6th ed. San Diego (CA): Elsevier, Academic Press.
   Google Scholar
• Reddy DS. (2011). Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front Endocrinol 2:1–11.
   PubMedGoogle Scholar
• Reddy DS, Kulkarni SK. (1996). Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the antistress activity of neurosteroids in mice. Psychopharmacology 128:280–92.
   PubMed Web of Science ®Google Scholar
• Reddy SD, Reddy DS. (2015). Midazolam as an anticonvulsant antidote for organophosphate intoxication-A pharmacotherapeutic appraisal. Epilepsia 56:813–21.
   PubMed Web of Science ®Google Scholar
• Ribeiro JA, Sebastiao AM, De Mendonca A. (2002). Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377–92.
   PubMed Web of Science ®Google Scholar
• Rickett DL, Glenn JF, Beers ET. (1986). Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology 7:225–36.
   PubMed Web of Science ®Google Scholar
• Rougé-Pont F, Mayo W, Marinelli M, et al. (2002). The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens. Eur J Neurosci 16:169–73.
   PubMed Web of Science ®Google Scholar
• Schindler CW, Karcz-Kubicha M, Thorndike EB, et al. (2005). Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Br J Pharmacol 144:642–50.
   PubMed Web of Science ®Google Scholar
• Schüle C, Eser D, Baghai TC, et al. (2011). Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience 191:55–77.
   PubMed Web of Science ®Google Scholar
• Seeman P, Guan HC, Hirbec H. (2009). Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse 63:698–704.
   PubMed Web of Science ®Google Scholar
• Shih T-M. (1990). Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res 7:105–16.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Duniho SM, McDonough JH. (2003). Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 188:69–80.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Kan RK, McDonough JH. (2005). In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents. Chem Biol Interact 157-158:293–303.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Koviak TA, Capacio BR. (1991). Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Behav Rev 15:349–62.
   PubMed Web of Science ®Google Scholar
• Shih T-M, McDonough JH. (1997). Neurochemical mechanisms in soman-induced seizures. J Appl Toxicol 17:255–64.
   PubMed Web of Science ®Google Scholar
• Shih T-M, McDonough JH, Koplovitz I. (1999). Anticonvulsants for soman-induced seizure activity. J Biomed Sci 6:86–96.
   PubMed Web of Science ®Google Scholar
• Shih T-M, McDonough JH. (1999). Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol Biochem Behav 64:147–53.
   PubMed Web of Science ®Google Scholar
• Shih T-M, Penetar DM, McDonough JH, et al. (1990). Age-related differences in soman toxicity and in blood and brain regional cholinesterase activity. Brain Res Bull 24:429–36.
   PubMed Web of Science ®Google Scholar
• Sidell FR. (1974). Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol 7:1–17.
   PubMed Web of Science ®Google Scholar
• Sivakumar S, Ibrahim M, Parker D, et al. (2015). Clobazam: an effective add-on therapy in refractory status epilepticus. Epilepsia 56:e83–9.
   PubMed Web of Science ®Google Scholar
• Skovira JW, Shih T-M, McDonough JH. (2012). Neuropharmacological specificity of brain structures involved in soman-induced seizures. Neurotoxicology 33:463–8.
   PubMed Web of Science ®Google Scholar
• Song WJ, Tkatch T, Surmeier DJ. (2000). Adenosine receptor expression and modulation of Ca(2+) channels in rat striatal cholinergic interneurons. J Neurophysiol 83:322–32.
   PubMed Web of Science ®Google Scholar
• Stewart WA, Harrison R, Dooley JM. (2002). Respiratory depression in the acute management of seizures. Arch Dis Child 87:225–6.
   PubMed Web of Science ®Google Scholar
• Taylor P. (2011). Anticholinesterase agents. In: Brunton LL, Chabner BA, Knollmann BC eds. Goodman and Gilman’s The pharmacological basis of therapeutics. 12th ed. New York (NY): McGraw-Hill, 239–54.
   Google Scholar
• Thiermann H, Worek F, Kehe K. (2013). Limitations and challenges in treatment of acute chemical warfare agent poisoning. Chem Biol Interact 206:435–43.
   PubMed Web of Science ®Google Scholar
• Thomas TP, Shih T-M. (2014). Stimulation of central A1 adenosine receptors suppresses seizure and neuropathology in a soman nerve agent seizure rat model. Toxicol Mech Methods 24:385–95.
   PubMed Web of Science ®Google Scholar
• Tonduli LS, Testylier G, Pernot-Marino I, Lallement G. (1999). Triggering of soman induced seizures in rats: multiparametric analysis with special correlation between enzymatic, neurochemical and electrophysiological data. J Neurosci Res 58:464–73.
   PubMed Web of Science ®Google Scholar
• Vale JA, Scott GW. (1974). Organophosphorus poisoning. Guys Hosp Rep 123:13–25.
   PubMedGoogle Scholar
• Watkins JC, Evans RH. (1981). Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 21:165–204.
   PubMed Web of Science ®Google Scholar
• Yager LM, Garcia AF, Wunsch AM, Ferguson SM. (2015). The ins and outs of the striatum: role in drug addiction. Neuroscience 301:529–41.
   PubMed Web of Science ®Google Scholar